생명과학회지 (Journal of Life Science)

  • 제15권4호
  • /
  • Pages.542-547
  • /
  • 2005
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

재조합 비의존적 경로를 통한 DNA 사슬간 교차결합 복구에의 Brca1단백질의 기능

Involvement of Brca1 in DNA Interstrand Cross-link Repair Through Homologous Recombination-independent Process

  • Yun, Jean-Ho (Medical Research Center for Cancer Molecular Therapy, College of Medicine, Dong-A University, Department of Biochemistry, College of Medicine, Dong-A University)
  • 발행 : 2005.08.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

시스플래틴이나 마이토마이신 C (MMC)와 같은 DNA 사슬간 교차결합 (interstrand cross-link ; ICL) 물질에 대해 Brca1 결손세포들이 보이는 높은 감수성은 Brca1 단백질이 세포의 ICL복구반응에 중요한 역할을 담당하고 있음을 암시하고 있다. Brca1 단백질은 재조합 의존성 또는 재조합 비의존성 경로를 통한 DNA 이중사슬 절단(double-strand break ; DSB) 복구에 필수적인 역할을 담당한다. 최근 본인이 속한 연구그룹에서 재조합 의존성 경로를 통한 세포의 ICL복구반응에 Brca1이 관여한다는 것을 밝혀 보고한바 있다. 본 연구에서는 Brca1 단백질의 재조합 비의존성 복구반응에 대한 관여여부를 $p53^{-/-}$와 $p53^{-/-}\;Brcal^{-/-}$ 세포주를 사용하여 연구하였다. 교차결합 복구 실험에서 Brca1 결손 세포주는 Brca1 정상 세포주보다 현저히 낮은 활성을 보였다. 또한, Brca1 결손세포 주의 MMC 에 대한 감수성과 ICL복구능이 Brca1 단백질 발현을 통해 회복되는 것을 확인하였다. 흥미롭게도, Brca1의 11번 엑손 결손세포주 $(Brca1^{\Delta11})$는 높은 MMC저항성과 ICL 복구능을 보였다. 이러한 결과들을 종합하여 볼 때, Brca1 단백질은 ICL복구에 재조합 의존성 경로뿐만 아니라 재조합 비의존성 경로를 통해서도 관여하며, 이러한 활성에는 엑손 11 부분이 아닌 N 말단의 RING 핑거 도메인이나 C 말단의 BRCT도메인이 중요하다는 것을 알 수 있다.

Hypersensitivity of cells lacking Brcal to DNA interstrand .ross-link (ICL) agents such as cisplatin and mitomycin C(MMC) implicates the important role of Brcal in cellular response following ICL treatment. Brca1 plays an essential role in DNA double-strand break (DSB) repair through homologous recombination (HR)-dependent and -independent process. Recently, our group has been reported that Brca1 involves in cellular ICL response through HR-dependent repair process (Yun J. et at., Oncogene 2005). In this report, the involvement of Brca1 protein in HR-independent repair process is examined using isogenic $p53^{-/-}\;and\;p53^{-/-}\;Brcal^{-/-}$ mouse embryonic fibroblast (MEF) and psoralen cross-linked reporter reactivation assay. Brcal-deficient MEFs showed significantly low HR-independent repair activity compare to Brca1-proficient MEFs. Hypersensitivity to MMC and ICL reporter repair activity were restored by the reconstitution of Brca1 expression. Interestingly, MEFs expressing exon 11-deleted isoform of Brca1 $(Brca1^{\Delta11/\Delta11})$ showed high resistance to MMC and ICL reporter repair activity comparable to Brca1-reconstituted MEFs. Taken together, these results suggest that Brca1 involves in ICL repair through not only HR-dependent process but also HR-independent process using N-terminal RINC finger domain or C-terminal BRCT domain rather than exon 11 region which mediate interaction with Rad50.

키워드

참고문헌

  1. Metzler, M. 1986. DNA adducts of medicinal drugs: some selected examples. J Cancer Res Clin Oncol, 112, 210-215 https://doi.org/10.1007/BF00395914
  2. Dronkert, M L., and Kanaar, R. 2001. Repair of DNA interstrand cross-links. Mutat Res, 486, 217-247 https://doi.org/10.1016/S0921-8777(01)00092-1
  3. Rothfuss, A, and Grompe, M. 2004. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol Cell Biol, 24, 123-134 https://doi.org/10.1128/MCB.24.1.123-134.2004
  4. Berardini, M, Mackay, W., and Loechler, E. L. 1997. Evidence for a recombination-independent pathway for the repair of DNA interstrand cross-links based on a site-specific study with nitrogen mustard. Biochemistry, 36, 3506-3513 https://doi.org/10.1021/bi962778w
  5. McHugh, P. J., Sones, W. R., and Hartley, J. A 2000. Repair of intermediate structures produced at DNA interstrand cross-links in Saccharomyces cerevisiae. Mol Cell Biol, 20, 3425-3433 https://doi.org/10.1128/MCB.20.10.3425-3433.2000
  6. Wang, X., Peterson, C. A., Zheng, H., Nairn, R. S., Legerski, R. J., and Li, L. 2001. Involvement of nucleotide excision repair in a recombination- independent and error-prone pathway of DNA interstrand cross-link repair. Mol Cell Biol, 21, 713-720 https://doi.org/10.1128/MCB.21.3.713-720.2001
  7. Bhattacharyya, A, Ear, U. S., Koller, B. H., Weichselbaum, R. R., and Bishop, D. K. 2000. The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem, 275, 23899-23903 https://doi.org/10.1074/jbc.C000276200
  8. Moynahan, M E., Cui, T. Y., and Jasin, M. 2001. Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation. Cancer Res, 61, 4842-4850
  9. Yu, V. P., Koehler, M., Steinlein, C., Schmid, M., Hanakahi, L. A, van Gool, A. J., West, S. C., and Venkitaraman, A R. 2000. Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation. Genes Dev, 14, 1400-1406
  10. Ting, N. S., and Lee, W. H. 2004. The DNA double-strand break response pathway: becoming more BRCAish than ever. DNA Repair (Amst), 3, 935-944 https://doi.org/10.1016/j.dnarep.2004.03.026
  11. Zheng, L., Li, S., Boyer, T. G., and Lee, W. H. 2000. Lessons learned from BRCA1 and BRCA2. Oncogene, 19, 6159-6175 https://doi.org/10.1038/sj.onc.1203968
  12. Yun, J., Zhong, Q., Kwak, J. Y., and Lee, W. H. 2005. Hypersensitivity of Brca1-deficient MEF to the DNA interstrand crosslinking agent mitomycin C is associated with defect in homologous recombination repair and aberrant S-phase arrest. Oncogene, 24, 4009-4016 https://doi.org/10.1038/sj.onc.1208575
  13. Zheng, L., Pan, H., Li, S., Flesken-Nikitin, A, Chen, P. J., Boyer, T. G., and Lee, W. H. 2000. Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1. Mol Cell, 6, 757-768 https://doi.org/10.1016/S1097-2765(00)00075-7
  14. Xu, X., Weaver, Z., Linke, S. P., Li, C., Gotay, J., Wang, X. W., Harris, C. C., Ried, T., and Deng, C. X. 1999. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell, 3, 389-395 https://doi.org/10.1016/S1097-2765(00)80466-9
  15. Aprelikova, O., Pace, A J., Fang, B., Koller, B. H., and Liu, E. T. 2001. BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. J Biol Chem, 276, 25647-25650
  16. Pear, W. S., Nolan, G. P., Scott, M. L., and Baltimore, D. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA, 90, 8392-8396
  17. Deng, C. X. 2001. Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice. Mutat Res, 477, 183-189 https://doi.org/10.1016/S0027-5107(01)00119-1
  18. Huber, L. J., Yang, T. W., Sarkisian, C. J., Master, S. R., Deng, C. X., and Chodosh, L. A 2001. Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci. Mol Cell Biol, 21, 4005-4015 https://doi.org/10.1128/MCB.21.12.4005-4015.2001